Immunovant, Inc. · NASDAQ:IMVT
Stout Jay S sold 40,000 Immunovant, Inc. shares (Form 4)
Traded Jun 26, 2026 · Filed Jun 26, 2026
On Jun 26, 2026, Stout Jay S (Chief Technology Officer) sold 40,000 Immunovant, Inc. shares at an average US$38.31 for US$1.53M, leaving 211,685 shares. Filed Jun 26, 2026 (Form 4).
- Sold
- 40,000 shares
- Price
- US$38.31 average (US$38.18 to US$38.94)
- Value
- US$1.53M
- Holding after
- 211,685 shares
- Trading plan
- No
- Role
- Chief Technology Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | Sale | 33,277 | US$38.18 | 218,408 | Direct |
| Jun 26, 2026 | Common Stock | Sale | 6,723 | US$38.94 | 211,685 | Direct |
Source
Related
- Immunovant, Inc.
- Stout Jay S
- Immunovant, Inc. shareholders
- Form 4 · Stout Jay S · Oct 9, 2026
- Form 4 · Stout Jay S · Jul 24, 2026
- Form 4 · Stout Jay S · Jul 10, 2026
- Form 4 · Stout Jay S · Apr 24, 2026
- Form 4 · Stout Jay S · Apr 10, 2026
- Form 4 · Gloria Melanie · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Oct 9, 2026
- Form 4 · Venker Eric · Oct 5, 2026
- Form 4 · Van Tuyl Christopher · Sep 25, 2026
- Form 4 · Pande Atul · Aug 28, 2026